• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

冠状动脉支架支柱骨折:分类、患病率及临床关联

Coronary Stent Strut Fractures: Classification, Prevalence and Clinical Associations.

作者信息

Schochlow Katharina, Weissner Melissa, Blachutzik Florian, Boeder Niklas F, Tröbs Monique, Lorenz Liv, Dijkstra Jouke, Münzel Thomas, Achenbach Stephan, Nef Holger, Gori Tommaso

机构信息

Kardiologie 1, Zentrum für Kardiologie, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Langenbeckstraße 1, 55131 Mainz, Germany.

Med. Klinik 2, Universitätsklinikum Erlangen, Ulmenweg 18, 91054 Erlangen, Germany.

出版信息

J Clin Med. 2021 Apr 19;10(8):1765. doi: 10.3390/jcm10081765.

DOI:10.3390/jcm10081765
PMID:33921606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8072680/
Abstract

INTRODUCTION

The frequency, characteristics and clinical implications of Strut fractures (SFs) remain incompletely understood.

METHODS AND RESULTS

A total of 185 (160 patients) newer-generation drug-eluting stents (DES) were imaged. SFs were found in 21 DES (11.4%) and were classified in four patterns: one single stacked strut (41%); two or more stacked struts (23%); deformation without gap (27%); transection (9%). In multivariable analysis, calcific and bifurcation lesions were associated with SF in DES (OR: 3.5 [1.1-11] and 4.0 [2.2-7.2], < 0.05). Device eccentricity and asymmetry as well as optical coherence tomography (OCT) features of impaired strut healing were also associated with SF. The prevalence of fractures was similar in a set of 289 bioresorbable scaffolds (BRS). In a separate series of 20 device thromboses and 36 device restenoses, the prevalence of SF was higher (61.2% of DES and 66.7% of BRS, < 0.001 for both), with a higher frequency of complex SF patterns ( < 0.0001). In logistic regression analysis, fractures were a correlate of device complications ( < 0.0001, OR = 24.9 [5.6-111] for DES and OR = 6.0 [1.8-20] for BRS).

DISCUSSION

The prevalence of OCT-diagnosed SF was unexpectedly high in the setting of elective controls and it increased by about three-fold in the setting of device failure. Fractures were associated with increased lesion complexity and device asymmetry/eccentricity and were more frequent in the setting of device failure such as restenosis and thrombosis.

摘要

引言

支架骨折(SFs)的发生率、特征及临床意义仍未完全明确。

方法与结果

共对185个(160例患者)新一代药物洗脱支架(DES)进行成像。发现21个DES存在SFs(11.4%),并分为四种类型:单个堆叠支架(41%);两个或更多堆叠支架(23%);无间隙变形(27%);横断(9%)。多变量分析显示,钙化病变和分叉病变与DES中的SF相关(比值比:3.5 [1.1 - 11]和4.0 [2.2 - 7.2],P < 0.05)。支架偏心和不对称以及支架愈合受损的光学相干断层扫描(OCT)特征也与SF相关。在一组289个生物可吸收支架(BRS)中,骨折发生率相似。在另一组20例器械血栓形成和36例器械再狭窄病例中,SF的发生率更高(DES为61.2%,BRS为66.7%,两者P均< 0.001),复杂SF类型的频率更高(P < 0.0001)。逻辑回归分析显示,骨折与器械并发症相关(P < 0.0001,DES的比值比 = 24.9 [5.6 - 111],BRS的比值比 = 6.0 [1.8 - 20])。

讨论

在择期对照情况下,经OCT诊断的SF发生率意外地高,在器械故障情况下增加了约三倍。骨折与病变复杂性增加、器械不对称/偏心相关,在再狭窄和血栓形成等器械故障情况下更常见。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43cc/8072680/14af9c21ffa3/jcm-10-01765-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43cc/8072680/d179be413628/jcm-10-01765-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43cc/8072680/49b6c6f1b16e/jcm-10-01765-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43cc/8072680/235423bdc86c/jcm-10-01765-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43cc/8072680/e10ae0623229/jcm-10-01765-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43cc/8072680/14af9c21ffa3/jcm-10-01765-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43cc/8072680/d179be413628/jcm-10-01765-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43cc/8072680/49b6c6f1b16e/jcm-10-01765-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43cc/8072680/235423bdc86c/jcm-10-01765-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43cc/8072680/e10ae0623229/jcm-10-01765-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43cc/8072680/14af9c21ffa3/jcm-10-01765-g005.jpg

相似文献

1
Coronary Stent Strut Fractures: Classification, Prevalence and Clinical Associations.冠状动脉支架支柱骨折:分类、患病率及临床关联
J Clin Med. 2021 Apr 19;10(8):1765. doi: 10.3390/jcm10081765.
2
Comparison of acute expansion of bioresorbable vascular scaffolds versus metallic drug-eluting stents in different degrees of calcification: An Optical Coherence Tomography Study.不同钙化程度下生物可吸收血管支架与金属药物洗脱支架急性扩张情况的比较:一项光学相干断层扫描研究
Catheter Cardiovasc Interv. 2017 Apr;89(5):798-810. doi: 10.1002/ccd.26676. Epub 2016 Oct 7.
3
Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100.支架厚度对急性机械性能的影响:DESolve 150 和 DESolve 100 的光学相干断层扫描对比研究。
Int J Cardiol. 2017 Nov 1;246:74-79. doi: 10.1016/j.ijcard.2017.05.087. Epub 2017 May 24.
4
Incidence and imaging outcomes of acute scaffold disruption and late structural discontinuity after implantation of the absorb Everolimus-Eluting fully bioresorbable vascular scaffold: optical coherence tomography assessment in the ABSORB cohort B Trial (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).植入可吸收依维莫司洗脱完全生物可吸收血管支架后急性支架断裂和晚期结构不连续性的发生率和影像学结果:ABSORB 队列 B 试验的光学相干断层成像评估(生物可吸收依维莫司洗脱冠状动脉支架系统治疗初发原生冠状动脉病变患者的临床评价)。
JACC Cardiovasc Interv. 2014 Dec;7(12):1400-11. doi: 10.1016/j.jcin.2014.06.016.
5
ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.可吸收生物降解支架与第二代金属支架比较:100 例 OCT 指导下复杂病变治疗的对比研究。
JACC Cardiovasc Interv. 2014 Jul;7(7):741-50. doi: 10.1016/j.jcin.2014.01.165.
6
Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study.使用Angiolite®药物洗脱支架经皮冠状动脉介入治疗后3个月和6个月的光学相干断层扫描监测:ANCHOR研究。
Catheter Cardiovasc Interv. 2018 Feb 15;91(3):435-443. doi: 10.1002/ccd.27189. Epub 2017 Jul 14.
7
Real-World Bioresorbable Vascular Scaffold Experience Compared With Second-Generation Metallic Drug-Eluting Stents in Complex Coronary Lesions.复杂冠状动脉病变中生物可吸收血管支架与第二代金属药物洗脱支架的真实世界经验比较
J Invasive Cardiol. 2018 Jul;30(7):251-255. Epub 2018 Apr 15.
8
Incomplete stent apposition and delayed tissue coverage are more frequent in drug-eluting stents implanted during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction than in drug-eluting stents implanted for stable/unstable angina: insights from optical coherence tomography.在急性 ST 段抬高型心肌梗死患者行经皮冠状动脉介入治疗时植入药物洗脱支架时,不完全贴壁和延迟组织覆盖比在稳定/不稳定型心绞痛患者中植入药物洗脱支架时更常见:光学相干断层扫描的见解。
JACC Cardiovasc Interv. 2009 May;2(5):445-52. doi: 10.1016/j.jcin.2009.01.012.
9
Re-endothelialisation after Synergy stent and Absorb bioresorbable vascular scaffold implantation in acute myocardial infarction: COVER-AMI study.协同支架与依维莫司洗脱生物可吸收血管支架植入急性心肌梗死后的再内皮化:COVER-AMI研究
Trials. 2019 Apr 11;20(1):210. doi: 10.1186/s13063-019-3293-8.
10
Optical coherence tomography evaluation of late strut coverage patterns between first-generation drug-eluting stents and everolimus-eluting stent.第一代药物洗脱支架与依维莫司洗脱支架晚期支架覆盖模式的光学相干断层扫描评估
Catheter Cardiovasc Interv. 2014 Nov 1;84(5):720-6. doi: 10.1002/ccd.25235. Epub 2013 Oct 31.

引用本文的文献

1
From Mechanisms to Management: Tackling In-Stent Restenosis in the Drug-Eluting Stent Era.从机制到管理:应对药物洗脱支架时代的支架内再狭窄
Curr Cardiol Rep. 2025 Feb 11;27(1):53. doi: 10.1007/s11886-025-02193-z.
2
Coronary Stent Fracture Causing Myocardial Infarction: Case Report and Review of Literature.冠状动脉支架断裂导致心肌梗死:病例报告及文献综述
Rev Cardiovasc Med. 2022 Nov 16;23(11):384. doi: 10.31083/j.rcm2311384. eCollection 2022 Nov.
3
Postmortem diagnosis of coronary subacute stent thrombosis.冠状动脉亚急性支架内血栓形成的尸检诊断

本文引用的文献

1
Vascular Wall Reactions to Coronary Stents-Clinical Implications for Stent Failure.血管壁对冠状动脉支架的反应——支架失败的临床意义
Life (Basel). 2021 Jan 17;11(1):63. doi: 10.3390/life11010063.
2
Drug-eluting stent thrombosis: current and future perspectives.药物洗脱支架血栓形成:当前和未来的观点。
Cardiovasc Interv Ther. 2021 Apr;36(2):158-168. doi: 10.1007/s12928-021-00754-x. Epub 2021 Jan 13.
3
Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention.支架相关不良事件 >1 年经皮冠状动脉介入治疗后。
Arch Cardiol Mex. 2024;94(1):95-96. doi: 10.24875/ACM.23000057.
4
Early stent fractures in superficial femoral artery resulting multiple pseudoaneurysm formation within one year: a case report.股浅动脉早期支架断裂导致一年内形成多个假性动脉瘤:一例报告
CVIR Endovasc. 2023 Sep 9;6(1):45. doi: 10.1186/s42155-023-00391-w.
5
Is There an Advantage of Ultrathin-Strut Drug-Eluting Stents over Second- and Third-Generation Drug-Eluting Stents?超薄支柱药物洗脱支架相对于第二代和第三代药物洗脱支架有优势吗?
J Pers Med. 2023 Apr 28;13(5):753. doi: 10.3390/jpm13050753.
6
Incidence of coronary drug-eluting stent fracture: A systematic review and meta-analysis.冠状动脉药物洗脱支架断裂的发生率:一项系统评价与荟萃分析。
Front Cardiovasc Med. 2022 Aug 23;9:925912. doi: 10.3389/fcvm.2022.925912. eCollection 2022.
7
Intravascular imaging in coronary stent restenosis: Prevention, characterization, and management.冠状动脉支架再狭窄的血管内成像:预防、特征分析与管理。
Front Cardiovasc Med. 2022 Aug 9;9:843734. doi: 10.3389/fcvm.2022.843734. eCollection 2022.
J Am Coll Cardiol. 2020 Feb 18;75(6):590-604. doi: 10.1016/j.jacc.2019.11.058.
4
Fracture in drug-eluting stents increases focal intimal hyperplasia in the atherosclerosed rabbit iliac artery.药物洗脱支架内骨折增加动脉粥样硬化兔髂动脉的局部内膜增生。
Catheter Cardiovasc Interv. 2019 Feb 1;93(2):278-285. doi: 10.1002/ccd.27726. Epub 2018 Sep 23.
5
Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions.冠状动脉内影像学的临床应用。第 1 部分:冠状动脉介入治疗的指导和优化。欧洲经皮心血管介入治疗协会的专家共识文件。
Eur Heart J. 2018 Sep 14;39(35):3281-3300. doi: 10.1093/eurheartj/ehy285.
6
Restenosis, Stent Thrombosis, and Bleeding Complications: Navigating Between Scylla and Charybdis.再狭窄、支架血栓形成和出血并发症:在斯库拉和卡律布狄斯之间航行。
J Am Coll Cardiol. 2018 Apr 17;71(15):1676-1695. doi: 10.1016/j.jacc.2018.02.023.
7
Mechanisms of Very Late Bioresorbable Scaffold Thrombosis: The INVEST Registry.非常晚期生物可吸收支架血栓形成的机制:INVEST 注册研究。
J Am Coll Cardiol. 2017 Nov 7;70(19):2330-2344. doi: 10.1016/j.jacc.2017.09.014.
8
Incidence and Long-Term Clinical Impact of Late-Acquired Stent Fracture After Sirolimus-Eluting Stent Implantation in Narrowed Coronary Arteries.西罗莫司洗脱支架植入狭窄冠状动脉后迟发性支架断裂的发生率及长期临床影响
Am J Cardiol. 2017 Jul 1;120(1):55-62. doi: 10.1016/j.amjcard.2017.03.259. Epub 2017 Apr 12.
9
Incidence and Clinical Outcomes of Stent Fractures on the Basis of 6,555 Patients and 16,482 Drug-Eluting Stents From 4 Centers.基于 4 家中心的 6555 名患者和 16482 枚药物洗脱支架的支架断裂发生率和临床结局。
JACC Cardiovasc Interv. 2016 Jun 13;9(11):1115-23. doi: 10.1016/j.jcin.2016.02.025. Epub 2016 Mar 18.
10
Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry.光学相干断层成像术分析支架内血栓形成的机制:来自法国全国 PESTO 登记研究的见解。
Eur Heart J. 2016 Apr 14;37(15):1208-16. doi: 10.1093/eurheartj/ehv711. Epub 2016 Jan 12.